相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。MicroRNA-34a-5p serves as a tumor suppressor by regulating the cell motility of bladder cancer cells through matrix metalloproteinase-2 silencing
Kuang-Yu Chou et al.
ONCOLOGY REPORTS (2021)
miR-34a-5p might have an important role for inducing apoptosis by down-regulation of SNAI1 in apigenin-treated lung cancer cells
Rieko Aida et al.
MOLECULAR BIOLOGY REPORTS (2021)
AXL Receptor in Cancer Metastasis and Drug Resistance: When Normal Functions Go Askew
Almira Auyez et al.
CANCERS (2021)
Oxidative Stress-Related Mechanisms in Melanoma and in the Acquired Resistance to Targeted Therapies
Stefania Pizzimenti et al.
ANTIOXIDANTS (2021)
miR-34a inhibits melanoma growth by targeting ZEB1
Yazhen Xu et al.
AGING-US (2021)
The role of Hypoxia-Inducible Factor-1alpha and its signaling in melanoma
Mohammad Malekan et al.
BIOMEDICINE & PHARMACOTHERAPY (2021)
The crystal structure of the domain-swapped dimer of onconase highlights some catalytic and antitumor activity features of the enzyme
Giovanni Gotte et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES (2021)
Circ-0005105 activates COL11A1 by targeting miR-20a-3p to promote pancreatic ductal adenocarcinoma progression
Gang Ma et al.
CELL DEATH & DISEASE (2021)
Expression and function of FRA1 protein in tumors
Xiaoyan Jiang et al.
MOLECULAR BIOLOGY REPORTS (2020)
Regulatory Mechanism of MicroRNA Expression in Cancer
Zainab Ali Syeda et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Function and mechanisms of microRNA-20a in colorectal cancer
Zheng Xiao et al.
EXPERIMENTAL AND THERAPEUTIC MEDICINE (2020)
The nuclear oncoprotein Fra-1: a transcription factor knocking on therapeutic applications' door
Francesco Talotta et al.
ONCOGENE (2020)
Yunpi Heluo decoction attenuates insulin resistance by regulating liver miR-29a-3p in Zucker diabetic fatty rats
Zhu-Jun Mao et al.
JOURNAL OF ETHNOPHARMACOLOGY (2019)
Influence of onconase in the therapeutic potential of PARP inhibitors in A375 malignant melanoma cells
Alice Raineri et al.
BIOCHEMICAL PHARMACOLOGY (2019)
MiR-29a function as tumor suppressor in cervical cancer by targeting SIRT1 and predict patient prognosis
Ping Nan et al.
ONCOTARGETS AND THERAPY (2019)
Onconase Restores Cytotoxicity in Dabrafenib-Resistant A375 Human Melanoma Cells and Affects Cell Migration, Invasion and Colony Formation Capability
Alice Raineri et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Biological Activities of Secretory RNases: Focus on Their Oligomerization to Design Antitumor Drugs
Giovanni Gotte et al.
FRONTIERS IN IMMUNOLOGY (2019)
The biochemical basis of microRNA targeting efficacy
Sean E. McGeary et al.
SCIENCE (2019)
1 A Systematic Review of miR-29 in Cancer
Jason J. Kwon et al.
MOLECULAR THERAPY-ONCOLYTICS (2019)
Epithelial-to-mesenchymal transition: lessons from development, insights into cancer and the potential of EMT-subtype based therapeutic intervention
Jane Antony et al.
PHYSICAL BIOLOGY (2019)
Expression Level of miR-34a in Tumor Tissue from Patients with Esophageal Squamous Cell Carcinoma
Milad Asadi et al.
JOURNAL OF GASTROINTESTINAL CANCER (2019)
Inhibition of integrin beta 1-mediated oncogenic signalling by the antitumor microRNA-29 family in head and neck squamous cell carcinoma
Keiichi Koshizuka et al.
ONCOTARGET (2018)
MiR-20a-5p suppresses tumor proliferation by targeting autophagy-related gene 7 in neuroblastoma
Yongbo Yu et al.
CANCER CELL INTERNATIONAL (2018)
MicroRNA-29a-3p Downregulation Causes Gab1 Upregulation to Promote Glioma Cell Proliferation
Nai-yuan Shao et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2018)
MiR-20a-3p regulates TGF-beta 1/Survivin pathway to affect keratinocytes proliferation and apoptosis by targeting SFMBT1 in vitro
Ronghua Li et al.
CELLULAR SIGNALLING (2018)
SOX2-mediated upregulation of CD24 promotes adaptive resistance toward targeted therapy in melanoma
Laura Hueser et al.
INTERNATIONAL JOURNAL OF CANCER (2018)
miR-29a-3p represses proliferation and metastasis of gastric cancer cells via attenuating HAS3 levels
Feihu Bai et al.
MOLECULAR MEDICINE REPORTS (2018)
AXL/AKT axis mediated-resistance to BRAF inhibitor depends on PTEN status in melanoma
Qiang Zuo et al.
ONCOGENE (2018)
Angiogenic role of miR-20a in breast cancer
Gines Luengo-Gil et al.
PLOS ONE (2018)
SIRT1 induces epithelial-mesenchymal transition by promoting autophagic degradation of E-cadherin in melanoma cells
Ting Sun et al.
CELL DEATH & DISEASE (2018)
miR-34a exerts as a key regulator in the dedifferentiation of osteosarcoma via PAI-1-Sox2 axis
Yu Zhang et al.
CELL DEATH & DISEASE (2018)
UBE2N Promotes Melanoma Growth via MEK/FRA1/SOX10 Signaling
Anushka Dikshit et al.
CANCER RESEARCH (2018)
Targeting Cyclin-Dependent Kinases for Treatment of Gynecologic Cancers
Z. Ping Lin et al.
FRONTIERS IN ONCOLOGY (2018)
HGF/c-MET Signaling in Melanocytes and Melanoma
Malgorzata Czyz
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
MicroRNA-29a Inhibits Growth, Migration and Invasion of Melanoma A375 Cells in Vitro by Directly Targeting BMI1
Ying Xiong et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2018)
Molecular Pathways: Receptor Ectodomain Shedding in Treatment, Resistance, and Monitoring of Cancer
Miles A. Miller et al.
CLINICAL CANCER RESEARCH (2017)
Genome-wide analysis of aberrantly expressed lncRNAs and miRNAs with associated co-expression and ceRNA networks in β-thalassemia and hereditary persistence of fetal hemoglobin
Ketong Lai et al.
ONCOTARGET (2017)
MLK3 regulates FRA-1 and MMPs to drive invasion and transendothelial migration in triple-negative breast cancer cells
C. Rattanasinchai et al.
ONCOGENESIS (2017)
Magnesium isoglycyrrhizinate shows hepatoprotective effects in a cyclophosphamide-induced model of hepatic injury
Wenjiao Jiang et al.
ONCOTARGET (2017)
Onconase dimerization through 3D domain swapping: structural investigations and increase in the apoptotic effect in cancer cells
Andrea Fagagnini et al.
BIOCHEMICAL JOURNAL (2017)
miR-34a Silences c-SRC to Attenuate Tumor Growth in Triple-Negative Breast Cancer
Brian D. Adams et al.
CANCER RESEARCH (2016)
Tumor-suppressive microRNA-29 family inhibits cancer cell migration and invasion directly targeting LOXL2 in lung squamous cell carcinoma
Keiko Mizuno et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2016)
Targeting metabolic reprogramming as a potential therapeutic strategy in melanoma
Lorey K. Smith et al.
PHARMACOLOGICAL RESEARCH (2016)
Restoration of miR-20a expression suppresses cell proliferation, migration, and invasion in HepG2 cells
Guang Shun Chen et al.
ONCOTARGETS AND THERAPY (2016)
LncRNAs and neoplasia
Mustafa Isin et al.
CLINICA CHIMICA ACTA (2015)
MicroRNA-34a regulates epithelial-mesenchymal transition and cancer stem cell phenotype of head and neck squamous cell carcinoma in vitro
Zhifeng Sun et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2015)
5-Aminolevulinic acid-mediated sonodynamic therapy induces anti-tumor effects in malignant melanoma via p53-miR-34a-Sirt1 axis
Zheng Hu et al.
JOURNAL OF DERMATOLOGICAL SCIENCE (2015)
Inhibition of uPAR-TGFβ crosstalk blocks MSC-dependent EMT in melanoma cells
Anna Laurenzana et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2015)
Inhibition of tumor growth by β-elemene through downregulation of the expression of uPA, uPAR, MMP-2, and MMP-9 in a murine intraocular melanoma model
Hong Shi et al.
MELANOMA RESEARCH (2015)
Cancer metabolism and the Warburg effect: the role of HIF-1 and PI3K
Rupert Courtnay et al.
MOLECULAR BIOLOGY REPORTS (2015)
miR-34a-5p suppresses colorectal cancer metastasis and predicts recurrence in patients with stage II/III colorectal cancer
J. Gao et al.
ONCOGENE (2015)
The multiMiR R package and database: integration of microRNA-target interactions along with their disease and drug associations
Yuanbin Ru et al.
NUCLEIC ACIDS RESEARCH (2014)
Circulating MicroRNAs as Easy-to-Measure Aging Biomarkers in Older Breast Cancer Patients: Correlation with Chronological Age but Not with Fitness/Frailty Status
Sigrid Hatse et al.
PLOS ONE (2014)
Mir-34: A New Weapon Against Cancer?
Gabriella Misso et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2014)
MicroRNA-34 suppresses breast cancer invasion and metastasis by directly targeting Fra-1
S. Yang et al.
ONCOGENE (2013)
Emerging molecular targets in melanoma invasion and metastasis
Jose L. Orgaz et al.
PIGMENT CELL & MELANOMA RESEARCH (2013)
MicroRNA-34a inhibits migration and invasion of colon cancer cells via targeting to Fra-1
Jianmin Wu et al.
CARCINOGENESIS (2012)
Onconase downregulates microRNA expression through targeting microRNA precursorsFG
Meng Qiao et al.
CELL RESEARCH (2012)
Marked, Homogeneous, and Early [18F]Fluorodeoxyglucose-Positron Emission Tomography Responses to Vemurafenib in BRAF-Mutant Advanced Melanoma
Grant A. McArthur et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
SOX2 contributes to melanoma cell invasion
Sasha D. Girouard et al.
LABORATORY INVESTIGATION (2012)
TarBase 6.0: capturing the exponential growth of miRNA targets with experimental support
Thanasis Vergoulis et al.
NUCLEIC ACIDS RESEARCH (2012)
doRiNA: a database of RNA interactions in post-transcriptional regulation
Gerd Anders et al.
NUCLEIC ACIDS RESEARCH (2012)
Multiple degradation pathways regulate versatile CIP/KIP CDK inhibitors
Natalia G. Starostina et al.
TRENDS IN CELL BIOLOGY (2012)
VennDiagram: a package for the generation of highly-customizable Venn and Euler diagrams in R
Hanbo Chen et al.
BMC BIOINFORMATICS (2011)
miRTarBase: a database curates experimentally validated microRNA-target interactions
Sheng-Da Hsu et al.
NUCLEIC ACIDS RESEARCH (2011)
DIANA-microT Web server upgrade supports Fly and Worm miRNA target prediction and bibliographic miRNA to disease association
Manolis Maragkakis et al.
NUCLEIC ACIDS RESEARCH (2011)
Onconase mediated NFKβ downregulation in malignant pleural mesothelioma
C. M. Goparaju et al.
ONCOGENE (2011)
Inhibition of c-Met with the Specific Small Molecule Tyrosine Kinase Inhibitor SU11274 Decreases Growth and Metastasis Formation of Experimental Human Melanoma
I. Kenessey et al.
CURRENT CANCER DRUG TARGETS (2010)
Constitutive HIF-1 activity in malignant melanoma
Silke Kuphal et al.
EUROPEAN JOURNAL OF CANCER (2010)
miRecords: an integrated resource for microRNA-target interactions
Feifei Xiao et al.
NUCLEIC ACIDS RESEARCH (2009)
MicroRNA-34a Inhibits Uveal Melanoma Cell Proliferation and Migration through Downregulation of c-Met
Dongsheng Yan et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2009)
Ribonucleases as novel chemotherapeutics - The ranpirnase example
J. Eugene Lee et al.
BIODRUGS (2008)
miRDB: A microRNA target prediction and functional annotation database with a wiki interface
Xiaowei Wang
RNA (2008)
miRBase: tools for microRNA genomics
Sam Griffiths-Jones et al.
NUCLEIC ACIDS RESEARCH (2008)
The microRNA.org resource: targets and expression
Doron Betel et al.
NUCLEIC ACIDS RESEARCH (2008)
The role of site accessibility in microRNA target recognition
Michael Kertesz et al.
NATURE GENETICS (2007)
Cytotoxic ribonucleases: The dichotomy of coulombic forces
R. Jeremy Johnson et al.
BIOCHEMISTRY (2007)
Differential regulation of microRNAs by p53 revealed by massively parallel Sequencing -: miR-34a is a p53 target that induces apoptosis and G1-arrest
Valery Tarasov et al.
CELL CYCLE (2007)
Inference of miRNA targets using evolutionary conservation and pathway analysis
Dimos Gaidatzis et al.
BMC BIOINFORMATICS (2007)
RB and cell cycle progression
C. Giacinti et al.
ONCOGENE (2006)
Ranpirnase - an antitumour ribonuclease: its potential role in malignant mesothelioma
N Pavlakis et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2006)
HIF-1-mediated expression of pyruvate dehydrogenase kinase: A metabolic switch required for cellular adaptation to hypoxia
JW Kim et al.
CELL METABOLISM (2006)
Up-regulated expression of zonula occludens protein-1 in human melanoma associates with N-cadherin and contributes to invasion and adhesion
KSM Smalley et al.
AMERICAN JOURNAL OF PATHOLOGY (2005)
Ribonucleases as a novel pro-apoptotic anticancer strategy: Review of the preclinical and clinical data for ranpirnase
J Costanzi et al.
CANCER INVESTIGATION (2005)
Onconase: An unusually stable protein
E Notomista et al.
BIOCHEMISTRY (2000)
分享论文
